# CGM Use in Non-insulin Patients With DM2

Study · id `cardio:ct-nct07128342` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07128342](<https://clinicaltrials.gov/study/NCT07128342>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07128342

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07128342. Randomized; no masking; primary purpose treatment. Start 2025-11-01 (anticipated); primary completion 2027-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07128342, source copy `cardio:ctgov-nct07128342-2025-08-18`, retrieved 2026-10-26)
- Planned start: 2025-11-01 (anticipated) (ClinicalTrials.gov record NCT07128342, source copy `cardio:ctgov-nct07128342-2025-08-18`, retrieved 2026-10-26)
- Primary completion: 2027-11 (anticipated) (ClinicalTrials.gov record NCT07128342, source copy `cardio:ctgov-nct07128342-2025-08-18`, retrieved 2026-10-26)
- Completion: 2028-11 (anticipated) (ClinicalTrials.gov record NCT07128342, source copy `cardio:ctgov-nct07128342-2025-08-18`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07128342-2025-08-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: CGM Use in Non-insulin Patients With DM2
- Acronym: CGM-DWI
- Condition: Diabetes
- Condition: Type 2 Diabetes (T2DM)
- Condition: Obesity Type 2 Diabetes Mellitus
- Condition: Non Insulin Dependent Diabetes Mellitus
- Intervention (Device): CGM Group
- Intervention (Device): FSBG group
- Lead sponsor: Milwaukee VA Medical Center
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: d689240520890e192c9f8ad994f8f06383257db7d3736f5562278fa2906cfd01
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
